Latest News & Updates
The Nobel Prize winning director of the National Cancer Institute, Harold Varmus, MD, has tendered his resignation in a letter to President Barack Obama, citing economic restraints as a leading cause for his departure.
A nearly $1 billion windfall licensing agreement involving the immunotherapy PROSTVAC has the company Bavarian Nordic looking toward a long-term manufacturing and distribution arrangement with Bristol-Myers Squibb.
Acting 3 months ahead of schedule, the FDA approved nivolumab (Odivo) for patients with squamous non-small cell lung cancer.
Emmanuel S. Antonarakis, MBBCh, discusses research examining AR-V7 as a biomarker for chemotherapy efficacy in advanced prostate cancer.
The reduction of breast cancer risk with 5 years of tamoxifen does not outweigh the lack of a mortality benefit, according to J. Michael Dixon, MD, OBE, who shared his view in a session at the 32nd Annual Miami Breast Cancer Conference.
Latest Peer Exchange Discussions
Lecia Sequist, MD, Corey Langer, MD, and Mark Socinski, MD, describe the current and emerging strategies for treating acquired resistance to frontline tyrosine kinase inhibitors. View Now
In this segment, Anas Younes, MD, and John Sweetenham, MD, discuss treatment of relapsed and refractory Hodgkin lymphoma. View Now
In this segment, the panelists discuss RAS testing for patients with colorectal cancer. View Now
Most Popular Right Now
Online CME Activities